Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … M Correction Naghavi, H Wang, R Lozano, A Davis, X Liang, M Zhou, ... The Lancet 385 (9963), 117-171, 2015 | 5748 | 2015 |
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2514* | 2015 |
Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 NJ Kassebaum, A Bertozzi-Villa, MS Coggeshall, KA Shackelford, ... The Lancet 384 (9947), 980-1004, 2014 | 2057 | 2014 |
Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 H Wang, CA Liddell, MM Coates, MD Mooney, CE Levitz, AE Schumacher, ... The Lancet 384 (9947), 957-979, 2014 | 1064 | 2014 |
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 833 | 2018 |
Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 JN Newton, ADM Briggs, CJL Murray, D Dicker, KJ Foreman, H Wang, ... The Lancet 386 (10010), 2257-2274, 2015 | 431 | 2015 |
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 230 | 2024 |
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 218 | 2024 |
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 AM Thomson, TA McHugh, AP Oron, C Teply, N Lonberg, VV Tella, ... The Lancet Haematology 10 (8), e585-e599, 2023 | 216 | 2023 |
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 212 | 2024 |
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 183 | 2024 |
Left behind: widening disparities for males and females in US county life expectancy, 1985–2010 H Wang, AE Schumacher, CE Levitz, AH Mokdad, CJL Murray Population health metrics 11, 1-15, 2013 | 168 | 2013 |
Under-5 mortality in 2851 Chinese counties, 1996–2012: a subnational assessment of achieving MDG 4 goals in China Y Wang, X Li, M Zhou, S Luo, J Liang, CA Liddell, MM Coates, Y Gao, ... The Lancet 387 (10015), 273-283, 2016 | 144 | 2016 |
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis TJ Bollyky, E Castro, AY Aravkin, K Bhangdia, J Dalos, EN Hulland, ... The Lancet 401 (10385), 1341-1360, 2023 | 115 | 2023 |
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 79 | 2024 |
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 65 | 2024 |
Infarct collagen topography regulates fibroblast fate via p38-yes-associated protein transcriptional enhanced associate domain signals D Bugg, R Bretherton, P Kim, E Olszewski, A Nagle, AE Schumacher, ... Circulation research 127 (10), 1306-1322, 2020 | 55 | 2020 |
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The Lancet 403 (10440), 2057-2099, 2024 | 49 | 2024 |
Global, regional, and national burden of neck pain, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 AM Wu, M Cross, JM Elliott, GT Culbreth, LM Haile, JD Steinmetz, ... The Lancet Rheumatology 6 (3), e142-e155, 2024 | 48 | 2024 |
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases, 2024 | 20 | 2024 |